|Bid||22.21 x 0|
|Ask||22.28 x 0|
|Day's Range||22.20 - 23.70|
|52 Week Range||12.96 - 45.43|
|Beta (5Y Monthly)||2.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.99|
Despite the impact of the pandemic on the second quarter, Medical Product companies have shown strength on the back of huge adoption of COVID-19 related healthcare-support products and services.
Marijuana stocks fell after Canadian cannabis producer Cronos reported a steeper-than-expected Q2 loss.
Canopy Growth's new leadership is pruning operations after predecessors placed bets on small markets. So is the stock a buy?